GPD2 and prostate cancer: Notably, although mitochondrial glycerophosphate dehydrogenase (GPD2) has been implicated in the reoxidation of cytosolic NADH via the ETC in prostate cancer [70], due to compromised mitochondrial functions, this mechanism is unlikely to be at play in SCO2‐deficient HCT116 cells.